Pathway
Celiac disease mechanism and therapies
In celiac disease, gluten peptides breach the intestinal epithelial barrier and are deamidated by tissue transglutaminase 2 (TG2). These modified peptides are presented on HLA-DQ2 or HLA-DQ8 molecu...
WP:5562
What the reference databases state
Statements
13 statements
13 statements · 1 reference database · Subject: Celiac disease mechanism and therapies · Sources: WikiPathways
- CD4 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- DHODH participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- EGFR participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- F2RL1 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- GZMB participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- IFNG participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- IL15 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- IL2 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- IL21 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- ITGA4 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- ITGB7 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
- TGM2 participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only
Show the remaining 1
- TNF participates in Celiac disease mechanism and therapiesProteinWikiPathways WP5562Inferred only